One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-129107
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 25 |
Affiliation: Novartis (United States), University Hospital Würzburg, Peter MacCallum Cancer Centre, St Vincent's Hospital, University of Melbourne, Vienna General Hospital, Medical University of Vienna, Cornell University, University of Kansas, Oregon Health & Science University, University Hospital Cologne, Novartis (India), Hokkaido University Hospital, McMaster University, The Ohio State University, James Cancer Hospital, Université Paris Cité, Oslo University Hospital, Tokyo National Hospital, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Emory Healthcare, Emory Clinic, University of Pennsylvania, UPMC Hillman Cancer Center, Kyushu University Hospital, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, University of Minnesota, University of Chicago, Tris Pharma (United States), University of Michigan–Ann Arbor, Academic Medical Center, Royal Prince Alfred Hospital, Hospices Civils de Lyon
Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
